Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

Clinical trial NCT03066648 · COMPLETED

Trial details

NCT number: NCT03066648
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Bone Marrow Diseases Hematologic Diseases Chronic Myelomonocytic Leukemia

Start date: 2017-07-06
Primary completion: 2023-09-08
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.